Related Experiment Videos
[Persistent polyarticular synovitis after treatment with alendronate]
Louise Frederiksen1, Peter Junker, Kim T Brixen
1Odense Universitetshospital, Endokrinologisk Afdeling M. louisefrederiksen@tdcadsl.dk
Ugeskrift for Laeger
|May 9, 2007
Abstract:
A 62-year-old, previously healthy woman diagnosed with post-menopausal osteoporosis received alendronate 70 mg/week. One week after the first dose, she developed polyarticular synovitis in the hands, feet and knees. We suspect this to be an adverse reaction to alendronate. At follow-up after 14 months, the patient still had residual synovitis, mainly in the hands and finger joints, despite continued low-dose prednisolone therapy. Two additional cases of synovitis associated with bisphosphonate therapy have been reported in the literature. The pathophysiology behind this phenomenon is unknown.